Vitamin D deficiency and electrocardiographic subclinical myocardial injury: Results from National Health and Nutrition Examination Survey‐III

Association of cardiovascular disease (CVD) with nontraditional risk factors such as vitamin D deficiency has been examined previously. An investigation of the association of vitamin D with subclinical myocardial injury (SC‐MI) based on an electrocardiographic score is a simple, cost‐effective and innovative way to explore this relationship.

[1]  J. Zhou,et al.  Vitamin D in Vascular Calcification: A Double-Edged Sword? , 2018, Nutrients.

[2]  Kay-Tee Khaw,et al.  Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study: A Randomized Clinical Trial , 2017, JAMA cardiology.

[3]  Tong Liu,et al.  Meta‐analysis of Vitamin D Deficiency and Risk of Atrial Fibrillation , 2016, Clinical cardiology.

[4]  H. Suryapranata,et al.  Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[5]  Maithili Shenoy,et al.  Major Electrocardiographic Abnormalities and 25‐Hydroxy Vitamin D Deficiency: Insights from National Health and Nutrition Examination Survey‐III , 2014, Clinical cardiology.

[6]  Amit J. Shah,et al.  Subclinical myocardial injury identified by cardiac infarction/injury score and the risk of mortality in men and women free of cardiovascular disease. , 2014, The American journal of cardiology.

[7]  A. Avenell,et al.  Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. , 2014, The American journal of clinical nutrition.

[8]  J. Ioannidis,et al.  Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials , 2014, BMJ : British Medical Journal.

[9]  George R. Marzouka,et al.  QRS duration on electrocardiography and cardiovascular mortality (from the National Health and Nutrition Examination Survey-III). , 2013, The American journal of cardiology.

[10]  M. Holick,et al.  Vitamin D for health: a global perspective. , 2013, Mayo Clinic proceedings.

[11]  A. Noymer,et al.  Vitamin D (25OHD) Serum Seasonality in the United States , 2013, PloS one.

[12]  D. Lloyd‐Jones,et al.  Minor isolated Q waves and cardiovascular events in the MESA study. , 2013, The American journal of medicine.

[13]  V. Montori,et al.  Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. , 2011, The Journal of clinical endocrinology and metabolism.

[14]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[15]  R. Brugada,et al.  Serum 25-hydroxyvitamin D, calcium, phosphorus, and electrocardiographic QT interval duration: findings from NHANES III and ARIC. , 2011, The Journal of clinical endocrinology and metabolism.

[16]  B. Rosner,et al.  NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. , 2010, The Journal of nutrition.

[17]  T. Trikalinos,et al.  Systematic Review: Vitamin D and Cardiometabolic Outcomes , 2010, Annals of Internal Medicine.

[18]  M. Chonchol,et al.  25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. , 2009, Atherosclerosis.

[19]  D. Whellan,et al.  Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). , 2008, The American journal of cardiology.

[20]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[21]  A. Mitrakou,et al.  The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults , 2007, Diabetes Care.

[22]  R. Koerfer,et al.  Vitamin D and vascular calcification , 2007, Current opinion in lipidology.

[23]  J. Ayus,et al.  The role of vitamin D in left ventricular hypertrophy and cardiac function. , 2005, Kidney international. Supplement.

[24]  V. Froelicher,et al.  Electrocardiographic damage scores and cardiovascular mortality , 2005 .

[25]  A. K. Jarvis,et al.  1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. , 1997, The American journal of physiology.

[26]  P M Rautaharju,et al.  Cardiac Infarction Injury Score: An Electrocardiographic Coding Scheme for Ischemic Heart Disease , 1981, Circulation.

[27]  Ronald J. Prineas,et al.  The Minnesota code manual of electrocardiographic findings : including measurement and comparison with the Novacode : standards and procedures for ECG measurement in epidemiologic and clinical trials , 2010 .

[28]  G. Foster,et al.  The National Health and Nutrition Examination Survey , 2006 .

[29]  Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. , 1994, Vital and health statistics. Ser. 1, Programs and collection procedures.